Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Read Article
News
2024
2023
Archive
Search news articles
November 20, 2018
Sandoz and Pear Therapeutics Announce Launch Of reSET® For Treatment Of Patients With Substance Disorder
November 14, 2018
Cidara Therapeutics Named a San Diego Metro Area Top Workplace for Second Consecutive Year
November 14, 2018
Crinetics Pharmaceuticals Reports Third Quarter 2018 Financial Results
November 14, 2018
Homology Medicines Reports Third Quarter 2018 Financial Results
November 13, 2018
5AM Welcomes New Team Members: Partner Deborah Palestrant, Venture Partner Elliot Ehrich, General Counsel Galya Blachman
November 8, 2018
Cabaletta Bio Emerges Out of University of Pennsylvania to Develop CAAR T Cell Technology to Treat B Cell-mediated Autoimmune Diseases
November 8, 2018
Homology Medicines Presents Data on Platform’s Ability to Target the Central and Peripheral Nervous System and Therapeutic Potential in the Rare Disease Metachromatic Leukodystrophy
November 7, 2018
Flexion Therapeutics Reports Third-Quarter 2018 Financial Results and Recent Business Highlights
November 6, 2018
Audentes Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
November 5, 2018
Audentes Therapeutics Board of Directors Appoints Co-Founder and Chief Executive Officer Matthew R. Patterson as Chairman
« Previous Page
1
2
3
4
…
10
Next Page »